Combined assessment of reflow and collateral blood flow by myocardial contrast echocardiography after acute reperfused myocardial infarction

Heart

Volumn 82, Issue 1, 1999, Pages 62-67

  Leclercq, F ^a   Messner Pellenc, P ^a   Descours, Q ^a   Daures, J P ^a   Pasquie J L ^a   Hager, F X ^a   Davy, J M ^a   Grolleau Raoux, R ^a  

^a HÔPITAL ARNAUD DE VILLENEUVE   (France)

Author keywords

Collateral blood flow; Contrast echocardiography; Coronary reflow; Dobutamine echocardiography; Myocardial dysfunction

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTRAST ECHOCARDIOGRAPHY; CONTROLLED STUDY; CORONARY ARTERY COLLATERAL CIRCULATION; CORONARY ARTERY DILATATION; FEMALE; HEART MUSCLE BLOOD FLOW; HEART MUSCLE CONTRACTILITY; HEART MUSCLE REPERFUSION; HUMAN; MALE; PRIORITY JOURNAL; STRESS ECHOCARDIOGRAPHY;

EID: 0032989186     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.82.1.62     Document Type: Article

References (39)

1. 1 Kloner RA, Ganote CE, Jennings B. The no reflow phenomenon after temporary coronary occlusion in the dog. J Clin Invest 1974;54:1496-508.
2. 2 Krug A, Du Mesnil de Rochement W, Korb G. Blood supply to the myocardium after temporary coronary occlusion in the dog. Circ Res 1966;19:57-62.
3. 3 Ito H, Tomooka T, Sakai N, et al. Lack of myocardial perfusion immediately after successful thrombolysis. A predictor of poor recovery of left ventricular function in anterior myocardial infarction. Circulation 1992;85:1699-705.
4. 4 Illiceto S, Marangelli V, Marchese A, et al. Myocardial contrast echocardiography in acute myocardial infarction. Pathophysiological background and clinical applications. Eur Heart J 1996;17:344-53.
5. 5 Ito H, Maruyama A, Iwakura K, et al. Clinical implications of the no reflow phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation 1996;93:223-8.
6. 6 Illiceto S, Galiuto L, Marchese A, et al. Functional role of microvascular integrity in patients with infarci-related patency after acute myocardial infarction. Eur Heart J 1997;18:618-24.
7. 7 Bolognese L, Antoniucci D, Rovai D, et al. Myocardial contrast echocardiography versus dobutamine echocardiography for predicting functional recovery after acute myocardial infarction treated with primary coronary angioplasty. J Am Coll Cardiol 1996;28:1677-83.
8. 8 Ito H, Iwakura K, Oh H, et al. Temporal changes in myocardial perfusion patterns in patients with reperfused anterior wall myocardial infarction. Their relation to myocardial viability. Circulation 1995;91:656-62.
9. 9 Bax JJ, Valkema R, Visser FC, et al. FDG SPECT in the assessment of myocardial viability. Comparison with dobutamine echocardiography. Eur Heart J 1997;18(suppl D):D124-9.
10. 10 Sabia PJ, Powers ER, Ragosta M, et al. An association between collateral blood flow and myocardial viability in patients with recent myocardial infarction. N Engl J Med 1992;327:1825-31.
11. 11 Karagounis C, Sorensen SG, Menlove RL, et al, for the TEAM-2 Investigators. J Am Coll Cardiol 1992;19:1-10.
12. 12 Picano E, Mathias W, Pingitore A, et al, on behalf of the Echo Dobutamine International Cooperative Study Group. Safety and tolerability of dobutamine -atropine stress echocardiography: a prospective multicenter study, Lancet 1994;344:1190-2.
13. 13 Kaul S, Glasheen W, Ruddy TD, et al. The importance of defining left ventricular area at risk in vivo during acute myocardial infarction: an experimental evaluation with myocardial contrast two-dimensional echocardiography, Circulation 1987;75:1249-60.
14. 14 Kaul S. Dobutamine echocardiography for determining myocardial viability after reperfusion: experimental and clinical observations. Eur Heart J 1995;16(suppl M):17-23.
15. 15 Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantification of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 1989;2:358-67.
16. 16 Smart SC, Sawada S, Ryan T, et al. Low-dose dobutamine echocardiography detects reversible dysfunction after thrombolytic therapy of acute myocardial infarction. Circulation 1993;88:405-15.
17. 17 Leclercq F, Messner-Pellenc P, Moragues C, et al. Myocardial viability assessed by dobutamine echocardiography in acute myocardial infarction after successful primary coronary angioplasty. Am J Cardiol 1997;80:6-10.
18. 18 Ragosta M, Camarano G, Kaul S, et al. Microvascular integrity indicates myocellular viability in patients with recent myocardial infarction. New insights using myocardial contrast echocardiography. Circulation 1994,89:2562 9.
19. 19 Kaul S. Clinical applications of myocardial contrast echocardiography. Am J Cardiol 1992;69:46-55H.
20. 20 Feinstein S, Lang R, Neumann A. Contrast echocardiography during coronary arteriography in humans: perfusion and anatomic studies. J Am Coll Cardiol 1988;11:59-65.
21. 21 Lang R, Borow KM, Neumann A, et al. Effect of intracoronary injections of sonicated microbubbles on left ventricular contractility. Am J Cardiol 1987;60:166-71.
22. 22 Jeremy RW, Links JM, Becker LC. Progressive failure of coronary flow during reperfusion of myocardial infarction: documentation of the no reflow phenomenon with positron emission tomography. J Am Coll Cardiol 1990;16:695-704.
23. 23 White FC, Sanders M, Bloor CM. Regional redistribution of myocardial blood flow after coronary occlusion and reperfusion in the conscious dog. Am J Cardiol 1978;42:234-43.
24. 24 Villanueva FS, Glasheen WP, Sklenar J, et al. Characterization of spatial patterns of flow within the reperfused myocardium by myocardial contrast echocardiography. Implications in determining extent of myocardial salvage. Circulation 1993;88:2596-606.
25. 25 Illiceto S, Galiuto L, Marchese A, et al. Analysis of microvascular integrity, contractile reserve, and myocardial viability after acute myocardial infarction by dobutamine echocardiography and myocardial contrast echocardiography. Am J Cardiol 1996;77:441-5.
26. 26 Camarano G, Ragosta M, Gimple LW, et al. Identification of viable myocardium with contrast echocardiography in patients with poor left ventricular function caused by recent or remote myocardial infarction. Am J Cardiol 1995;75:215-19.
27. 27 Kenner M, Zajac EJ, Kondos GT, et al. Ability of the no-reflow phenomenon during an acute myocardial infarction to predict left ventricular dysfunction at one-month follow up. Am J Cardiol 1995;76:861-8.
28. 28 Cohen M, Rentrop KP. Limitation of myocardial ischemia by collateral circulation during sudden controlled coronary artery occlusion in human subjects: a prospective study. Circulation 1986;74:469-76.
29. 29 Sabia PJ, Powers ER, Jayaweera AR, et al. Functional significance of collateral blood flow in patients with recent acute myocardial infarction. A study using myocardial contrast echocardiography. Circulation 1992;85:2080-9.
30. 30 Widimsky P, Cornel JH, Ten Cate FJ. Evaluation of collateral blood flow by myocardial contrast echocardiography. Br Heart J 1988;59:20-2.
31. 31 Lim Y, Nanto S, Masuyama T, et al. Coronary collaterals assessed with myocardial contrast echocardiography in healed myocardial infarction. Am J Cardiol 1990;66:556-61.
32. 32 Saito Y, Yasuno M, Ishida M, et al. Importance of coronary collaterals for restoration of left ventricular function after intracoronary thrombolysis. Am J Cardiol 1985;55:1259-63.
33. 33 Rentrop KP, Feit F, Sherman W, et al. Late thrombolytic therapy preserves left ventricular function in patients with collateralized total coronary occlusion: primary end points findings of the second Mount Sinai New York University reperfusion trial. J Am Coll Cardiol 1989;14:58-64.
34. 34 Agati L, Voci P, Autore C, et al. Combined use of dobutamine echocardiography and myocardial contrast echocardiography in predicting regional dysfunction recovery after coronary revascularization in patients with recent myocardial infarction. Eur Heart J 1997;18:771-9.
35. 35 Marwick TH. The viable myocardium: epidemiology, detection, and clinical implications. Lancet 1998;351:815-19.
36. 36 De Filippi CR, Willett DL, Irani WN, et al. Comparison of myocardial contrast echocardiography and low-dose dobutamine echocardiography in predicting recovery of left ventricular function after coronary revascularization in chronic ischemic heart disease. Circulation 1995;92:2863-8.
37. 37 Rovai D, Zanchi M, Lombardi M, et al. Residual myocardial perfusion in reversibly damaged myocardium by dipyridamole contrast echocardiography. Eur Heart J 1996;17:296-301.
38. 38 Porter TR, Li S, Kilzer K, et al. Effect of significant two-vessel versus one-vessel coronary artery stenosis on myocardial contrast defects observed with intermittent harmonic imaging after intravenous contrast injection during dobutamine stress echocardiography. J Am Coll Cardiol 1997;30:1399-406.
39. 39 Kaul S, Senior R, Dittrich H, et al. Detection of coronary artery disease with myocardial contrast echocardiography. Comparison with 99m Tc-Sestamibi single-photon emission computed tomography. Circulation 1997;96:785-92.